OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RKT54

Rocketdna Ltd

Aerospace & DefenseVerified

Rocketdna's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This absence of data prevents a full assessment of the company's liquidity position. Profitability and return metrics are not available for Rocketdna, as the valuation snapshot does not include computed ratios such as ROIC or margins. Without these metrics, it is not possible to compare the company's performance against industry_config preferred metrics or cohort medians. Segment and geographic exposure data are not disclosed in the available financial snapshot, making it impossible to assess revenue concentration or geographic diversification. The company's exposure to specific markets or product lines remains unclear. Growth trajectory data is limited, as the outlook section does not provide numeric deltas or revenue history. The absence of forward-looking guidance and historical performance data hinders the ability to assess Rocketdna's growth potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and the lack of going-concern language in source documents. Additionally, the dilution potential is classified as low, but no specific sources or adjustments are provided to support this assessment. Recent events and filings are not detailed in the available data, so no specific information can be provided on recent corporate actions, earnings calls, or regulatory updates.

30-day price · RKT-1.39 (-9.3%)
Low$12.38High$17.36Close$13.63As of20 May, 00:00 UTC
Profile
CompanyRocketdna Ltd
TickerRKT.AX
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Rocketdna Ltd is an aerospace and defense company that provides electronic equipment, instruments, and components for industrial applications.

Classification. Rocketdna is classified under the Aerospace & Defense industry within the Industrial Goods business sector, with a confidence level of 0.92.

Rocketdna's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This absence of data prevents a full assessment of the company's liquidity position. Profitability and return metrics are not available for Rocketdna, as the valuation snapshot does not include computed ratios such as ROIC or margins. Without these metrics, it is not possible to compare the company's performance against industry_config preferred metrics or cohort medians. Segment and geographic exposure data are not disclosed in the available financial snapshot, making it impossible to assess revenue concentration or geographic diversification. The company's exposure to specific markets or product lines remains unclear. Growth trajectory data is limited, as the outlook section does not provide numeric deltas or revenue history. The absence of forward-looking guidance and historical performance data hinders the ability to assess Rocketdna's growth potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and the lack of going-concern language in source documents. Additionally, the dilution potential is classified as low, but no specific sources or adjustments are provided to support this assessment. Recent events and filings are not detailed in the available data, so no specific information can be provided on recent corporate actions, earnings calls, or regulatory updates.
Key takeaways
  • Rocketdna operates in the aerospace and defense industry, focusing on electronic equipment and components.
  • The company's liquidity position cannot be assessed due to missing balance-sheet data.
  • Profitability and return metrics are not available for comparison with industry benchmarks.
  • Growth trajectory and revenue history are not disclosed, limiting forward-looking analysis.
  • Risk factors include unassessable liquidity risk and limited visibility into recent corporate events.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$4.6M-$1.8M-$3.6M-$2.4M
FY-3$5.7M-$2.3M-$1.9M-$2.9M
FY-2$6.1M-$1.8M-$1.8M-$1.9M
FY-1$7.2M-$1.5M-$1.9M-$2.1M
FY0$7.7M-$2.7M-$2.8M-$3.4M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$11.3M$8.0M$954.9k
FY-3$7.0M$5.6M$2.3M
FY-2$6.8M$4.9M$2.3M
FY-1$8.4M$6.2M$3.4M
FY0$11.4M$7.9M$3.9M
PeriodOCFCapExFCFSBC
FY-4-$2.9M-$813.8k-$2.4M
FY-3-$1.5M-$795.2k-$2.9M
FY-2-$970.6k-$933.7k-$1.9M
FY-1-$506.3k-$1.2M-$2.1M
FY0-$1.5M-$2.0M-$3.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Aerospace & Defense · cohort 184 companies
MetricRKTActivity
Op margin6.6% medp25 -6.7% · p75 13.4%
Net margin4.7% medp25 -6.0% · p75 11.0%
Gross margin28.0% medp25 16.8% · p75 46.8%
R&D / revenue4.1% medp25 4.1% · p75 4.1%
CapEx / revenue-6.7% medp25 -17.5% · p75 -3.2%
Debt / equity16.5% medp25 3.2% · p75 44.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 05:10 UTC#2fe17822
Market quoteclose AUD 0.02 · shares 1.19B diluted
no public URL
2026-05-04 05:10 UTC#bbead9cc
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 05:24 UTCJob: a7de0912